Listen to this page using ReadSpeaker

Delaware News



  Category: Division of Professional Regulation


Secretary of State Renews Emergency Order Placing Xylazine in Schedule III

Department of State | Division of Professional Regulation | News | Date Posted: Monday, October 2, 2023

Pursuant to 29 Del.C. §10119(3), Delaware Secretary of State Jeff Bullock has renewed an Emergency Order placing xylazine, also known as “Tranq”, temporarily in Schedule III in the state of Delaware. The Emergency Order took effect June 2, 2023, and was effective 120 days. The public threat posed by xylazine continues. Therefore, the renewal of […]




Secretary of State Orders Emergency Classification of Xylazine aka “Tranq” as Schedule III Controlled Substance

Department of State | Division of Professional Regulation | News | Date Posted: Friday, June 2, 2023

Delaware Secretary of State Jeff Bullock has placed xylazine, also known as “Tranq”— a non-opioid drug used primarily in veterinary medicine—in Schedule III of the Uniform Controlled Substance Act. Tranq has been used increasingly as an additive in opioid abuse to create a “zombie-like” condition for users. Secretary Bullock’s actions follow a recommendation from the […]







  Category: Division of Professional Regulation


Secretary of State Renews Emergency Order Placing Xylazine in Schedule III

Department of State | Division of Professional Regulation | News | Date Posted: Monday, October 2, 2023

Pursuant to 29 Del.C. §10119(3), Delaware Secretary of State Jeff Bullock has renewed an Emergency Order placing xylazine, also known as “Tranq”, temporarily in Schedule III in the state of Delaware. The Emergency Order took effect June 2, 2023, and was effective 120 days. The public threat posed by xylazine continues. Therefore, the renewal of […]




Secretary of State Orders Emergency Classification of Xylazine aka “Tranq” as Schedule III Controlled Substance

Department of State | Division of Professional Regulation | News | Date Posted: Friday, June 2, 2023

Delaware Secretary of State Jeff Bullock has placed xylazine, also known as “Tranq”— a non-opioid drug used primarily in veterinary medicine—in Schedule III of the Uniform Controlled Substance Act. Tranq has been used increasingly as an additive in opioid abuse to create a “zombie-like” condition for users. Secretary Bullock’s actions follow a recommendation from the […]